Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

A. Barton | M. Mayes | J. D. de Vries-Bouwstra | T. Radstake | A. Gabrielli | C. Terao | M. González-Gay | L. Rodríguez-Rodríguez | L. Padyukov | A. Herrick | J. Pers | A. Saraux | V. Devauchelle-Pensec | L. Kovács | G. Orozco | N. Oreiro | G. Espinosa | C. Denton | Marcus John Beasley | M. Vonk | P. Carreira | Y. Allanore | M. Acosta-Herrera | B. Fernández-Gutiérrez | F. Hiepe | L. Beretta | M. Kerick | S. Jousse-Joulin | A. Hoffmann-Vold | E. de Ramón | T. Witte | D. Cornec | C. Chizzolini | N. Hunzelmann | A. Fernández-Nebro | M. Brandão | F. Farinha | G. Stummvoll | J. Callejas | N. Ortego | B. Lauwerys | C. Vasconcelos | S. Proudman | G. Moroncini | R. Hesselstrand | C. Fonseca | I. Castellví | M. Nikpour | L. Sáez-comet | M. Freire | C. Simeón-Aznar | M. Rischmueller | S. Assassi | J. Sahhar | J. Roddy | W. Stevens | R. Ortega-Castro | R. Lories | C. Lunardi | M. Gerosa | T. Schioppo | R. Aguilar-Quesada | J. Zochling | M. Zauner | S. Dulić | J. Distler | E. De Langhe | A. Balog | I. Almeida | A. Campar | R. Faria | A. Marinho | Esmeralda Neves | A. Tavares | B. Vigone | I. Rodríguez-Pintó | D. Belz | N. Baerlecken | M. Aguirre-Zamorano | M. Castro-Villegas | A. Escudero-Contreras | E. Raya | C. Artusi | J. Ducreux | A. Maudoux | Donatienne Wynar | M. Bocskai | M. Deák | G. Kádár | V. Gerl | Silvia Thiel | M. Maresca | R. B. Alonso | I. Quintero | María Concepción Fernández Roldán | Inmaculada Jiménez Moleón | F. Narváez | F. López-longo | M. Egurbide | A. Nordin | M. D. de Castro | P. G. de la Peña | A. Pros | E. Beltrán | K. Tymms | V. Ortiz-Santamaria | J. Román-Ivorra | B. Koeleman | S. Lester | M. Aguirre | Javier Martín | A. Voskuyl | E. Collantes | C. Tolosa | L. Trapiella | V. Fonollosa | G. Riemekasten | B. Díaz | J. Andreu | F. García-Hernández | R. Portales | R. Ríos | C. Magro | R. Cervera | Esther Vicente | J. A. Sancho | Michael Lehner | M. Mantecón | Alfonso Corrales Martínez | A. Zuber | A. López‐Berrio | H. Navarro‐Linares | M. R. Rivas | A. Madroñero | P. I. R. R. García A. F. J. M. A. B. L. P. García E. Carreira Castellvi Ríos Portales Fernández-Neb | A. Guillén | M. Carballeira | P. Fanlo-Mateo | F. Díaz | F. B. García | A. Kreuter | P. Airò | W. J. J. J. P. K. M. S. Stevens Zochling Sahhar Roddy Nash Tymms Rischmuel | P. Nash | Barbara Jacques-Olivier Alain Valérie Divi Sandrine Bernar Vigone Pers Saraux Devauchelle-Pensec Cor | M. Alarcón-Riquelme | P. Airó | A. Hoffmann‐Vold | J. Sancho | A. Barton | T. Witte | Anne‐Lise Maudoux | G. Espinosa | Héctor Navarro‐Linares | Ana Tavares | M. R. Maresca | G. Espinosa | T. Witte

[1]  C. Chizzolini,et al.  Current Concepts on the Pathogenesis of Systemic Sclerosis , 2021, Clinical Reviews in Allergy & Immunology.

[2]  Mengyao Liu,et al.  Complement C4, Infections, and Autoimmune Diseases , 2021, Frontiers in Immunology.

[3]  Yang I. Li,et al.  The impact of cell type and context-dependent regulatory variants on human immune traits , 2021, Genome biology.

[4]  A. Barton,et al.  Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes , 2021, Annals of the Rheumatic Diseases.

[5]  D. Chauveau,et al.  Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis–Induced Thrombotic Microangiopathies , 2021, Kidney international reports.

[6]  Javier Martín,et al.  Expression Quantitative Trait Locus Analysis in Systemic Sclerosis Identifies New Candidate Genes Associated With Multiple Aspects of Disease Pathology , 2021, Arthritis & rheumatology.

[7]  Ken-ichi Matsumoto,et al.  The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases , 2020, Frontiers in Immunology.

[8]  Fengchun Zhang,et al.  Association between complement 4 copy number variation and systemic lupus erythematosus: a meta-analysis , 2020, Clinical and Experimental Medicine.

[9]  Javier Martín,et al.  Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients , 2020, Annals of the Rheumatic Diseases.

[10]  S. Yusuf,et al.  Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study , 2020, The Lancet.

[11]  E. Ruppin,et al.  Predicting tissue-specific gene expression from whole blood transcriptome , 2020, Science Advances.

[12]  Simon C. Potter,et al.  Complement genes contribute sex-biased vulnerability in diverse illnesses , 2020, Nature.

[13]  E. Ballestar,et al.  Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases , 2020, Arthritis & rheumatology.

[14]  G. Remington,et al.  Association Study of the Complement Component C4 Gene in Tardive Dyskinesia , 2019, Front. Pharmacol..

[15]  Howard Y. Chang,et al.  GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways , 2019, Nature Communications.

[16]  P. Verpillat,et al.  Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease , 2019, Clinical epidemiology.

[17]  Brian E. Cade,et al.  Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program , 2019, Nature.

[18]  H. Noguchi,et al.  Interactions of HLA-DR and Topoisomerase I Epitope Modulated Genetic Risk for Systemic Sclerosis , 2019, Scientific Reports.

[19]  W. Marut,et al.  New insights into the genetics and epigenetics of systemic sclerosis , 2018, Nature Reviews Rheumatology.

[20]  Meilan K. Han,et al.  Female Sex and Gender in Lung/Sleep Health and Disease. Increased Understanding of Basic Biological, Pathophysiological, and Behavioral Mechanisms Leading to Better Health for Female Patients with Lung Disease , 2018, American journal of respiratory and critical care medicine.

[21]  M. López-Trascasa,et al.  Common and rare genetic variants of complement components in human disease , 2018, Molecular immunology.

[22]  M. Kolev,et al.  Complement and the Regulation of T Cell Responses. , 2018, Annual review of immunology.

[23]  M. Ingersoll.  Sex differences shape the response to infectious diseases , 2017, PLoS pathogens.

[24]  W. Lieb,et al.  Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus , 2017, Lupus.

[25]  K. Yin,et al.  Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease. , 2017, American journal of physiology. Heart and circulatory physiology.

[26]  M. Boubaya,et al.  Mapping and predicting mortality from systemic sclerosis , 2017, Annals of the rheumatic diseases.

[27]  P. Gregersen,et al.  Transancestral mapping and genetic load in systemic lupus erythematosus , 2017, Nature Communications.

[28]  James T. Elder,et al.  VGLL3-regulated gene network as a promoter of sex biased autoimmune diseases , 2016, Nature immunology.

[29]  J. Esposito,et al.  The association of low complement with disease activity in systemic sclerosis: a prospective cohort study , 2016, Arthritis Research & Therapy.

[30]  M. Goebeler,et al.  Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc) , 2016, Autoimmunity.

[31]  M. Jadoul,et al.  Complement activation and effect of eculizumab in scleroderma renal crisis , 2016, Medicine.

[32]  V. Devauchelle-Pensec,et al.  The active immunological profile in patients with primary Sjögren's syndrome is restricted to typically encountered autoantibodies. , 2016, Clinical and experimental rheumatology.

[33]  Florian Holsboer,et al.  Phenotypic Association Analyses With Copy Number Variation in Recurrent Depressive Disorder , 2016, Biological Psychiatry.

[34]  Giulio Genovese,et al.  Schizophrenia risk from complex variation of complement component 4 , 2016, Nature.

[35]  Javier Martín,et al.  Immunogenetics of systemic sclerosis: Defining heritability, functional variants and shared-autoimmunity pathways. , 2015, Journal of autoimmunity.

[36]  S. Mccarroll,et al.  Complex and multi-allelic copy number variation in human disease , 2015, Briefings in functional genomics.

[37]  G. Haraldsen,et al.  Tenascins in fibrotic disorders—from bench to bedside , 2015, Cell adhesion & migration.

[38]  C. Lethias,et al.  Tenascin-X: beyond the architectural function , 2015, Cell adhesion & migration.

[39]  D. Chaussabel,et al.  Low HERV-K(C4) Copy Number Is Associated With Type 1 Diabetes , 2014, Diabetes.

[40]  V. Holers.  Complement and its receptors: new insights into human disease. , 2014, Annual review of immunology.

[41]  Jun S. Liu,et al.  Genetics of rheumatoid arthritis contributes to biology and drug discovery , 2013 .

[42]  Oliver Distler,et al.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. , 2013, Arthritis and rheumatism.

[43]  M. Mayes,et al.  An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative , 2013 .

[44]  Buhm Han,et al.  Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens , 2013, PloS one.

[45]  James Y Dai,et al.  Two-stage testing procedures with independent filtering for genome-wide gene-environment interaction. , 2012, Biometrika.

[46]  R. Holmdahl,et al.  Copy number variation in autoimmunity — importance hidden in complexity? , 2012, European journal of immunology.

[47]  Á. Szilágyi,et al.  Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes , 2012, Genes and Immunity.

[48]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[49]  Eleazar Eskin,et al.  Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. , 2011, American journal of human genetics.

[50]  Marcel Martin.  Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[51]  M. Patarroyo,et al.  Quantum Chemical Analysis of MHC-Peptide Interactions for Vaccine Design , 2010, Mini reviews in medicinal chemistry.

[52]  Edinburgh Research Explorer Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples , 2022 .

[53]  Min Chen,et al.  The complement system in systemic autoimmune disease. , 2010, Journal of autoimmunity.

[54]  M. Hurles,et al.  Copy number variation in human health, disease, and evolution. , 2009, Annual review of genomics and human genetics.

[55]  A. Reymond,et al.  Copy number variants, diseases and gene expression. , 2009, Human molecular genetics.

[56]  P. Deloukas,et al.  Overview of the MHC fine mapping data , 2009, Diabetes, obesity & metabolism.

[57]  T. Kuijpers,et al.  High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's. , 2009, Molecular immunology.

[58]  Gonçalo Abecasis,et al.  Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis , 2009, Nature Genetics.

[59]  F. Schmidt.  Meta-Analysis , 2008 .

[60]  Bi Zhou,et al.  Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. , 2007, American journal of human genetics.

[61]  Philippe Froguel,et al.  FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity , 2007, Nature Genetics.

[62]  N. Risch,et al.  Estimation of individual admixture: Analytical and study design considerations , 2005, Genetic epidemiology.

[63]  C. Y. Yu,et al.  Diversity in Intrinsic Strengths of the Human Complement System: Serum C4 Protein Concentrations Correlate with C4 Gene Size and Polygenic Variations, Hemolytic Activities, and Body Mass Index 1 , 2003, The Journal of Immunology.

[64]  M. Gadjeva,et al.  Macrophage-Derived Complement Component C4 Can Restore Humoral Immunity in C4-Deficient Mice1 , 2002, The Journal of Immunology.

[65]  Martin Vingron,et al.  Variance stabilization applied to microarray data calibration and to the quantification of differential expression , 2002, ISMB.

[66]  T. Medsger,et al.  Criteria for the classification of early systemic sclerosis. , 2001, The Journal of rheumatology.

[67]  M. Walport.  Complement. First of two parts. , 2001, The New England journal of medicine.

[68]  C. Y. Yu,et al.  Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4. , 2001, International immunopharmacology.

[69]  Bi Zhou,et al.  Deficiencies of Human Complement Component C4a and C4b and Heterozygosity in Length Variants of RP-C4-CYP21-TNX (Rccx) Modules in Caucasians , 2000, The Journal of experimental medicine.

[70]  M. Walport,et al.  IFN-gamma up-regulates expression of the complement components C3 and C4 by stabilization of mRNA. , 1996, Journal of immunology.

[71]  N Rowell,et al.  Systemic sclerosis. , 1968, British medical journal.

[72]  D. Rujescu,et al.  The Complement C4 Genetic Diversity in First Episode Psychosis of the OPTiMiSE Cohort , 2021 .

[73]  John D Lambris,et al.  The renaissance of complement therapeutics , 2018, Nature Reviews Nephrology.

[74]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[75]  R. M. Ackay,et al.  First of Two Parts , 2013 .

[76]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[77]  A. Silman,et al.  Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .

[78]  G. Thorgeirsson,et al.  Low complement C4B gene copy number predicts short-term mortality after acute myocardial infarction. , 2008, International immunology.

[79]  W. Miller,et al.  Dancing with complement C4 and the RP-C4-CYP21-TNX (RCCX) modules of the major histocompatibility complex. , 2003, Progress in nucleic acid research and molecular biology.

[80]  M. Carroll,et al.  The role of complement and complement receptors in induction and regulation of immunity. , 1998, Annual review of immunology.